Thursday, January 6, 2022

Alembic Pharma gets final nod from USFDA for generic drug to treat Parkinson#39;s disease

Alembic Pharma gets final nod from USFDA for generic drug to treat Parkinson#39;s disease The approval by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Entacapone tablets is for strength of 200 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/32TUMQW

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...